About me
Dr. Cynthia Rothblum-Oviatt serves as the External Engagement Lead for the FDA’s Center for Drug Evaluation and Research (CDER) Rare Diseases Team within the Office of New Drugs. Prior to joining FDA, Dr. Rothblum-Oviatt spent approximately 20 years in the non-profit rare disease advocacy space. Dr. Rothblum-Oviatt earned her PhD in biochemistry from the George Washington University in the District of Columbia.
LinkedIn
